Dimensional Fund Advisors
OLMA icon

Dimensional Fund Advisors’s Olema Pharmaceuticals OLMA Stock Holding History

Dimensional Fund Advisors’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16.1M Buy
1,082,434
+123,790
+13% +$2.76M ﹤0.01% 2069
2025
Q4 		$24M Sell
958,644
-105,905
-10% -$1.88M 0.01% 1886
2025
Q3 		$10.4M Sell
1,064,549
-142,601
-12% -$856K ﹤0.01% 2288
2025
Q2 		$5.14M Sell
1,207,150
-112,029
-8% -$499K ﹤0.01% 2512
2025
Q1 		$4.96M Sell
1,319,179
-13,613
-1% -$68.5K ﹤0.01% 2499
2024
Q4 		$7.77M Sell
1,332,792
-44,132
-3% -$441K ﹤0.01% 2402
2024
Q3 		$16.4M Sell
1,376,924
-308,000
-18% -$3.94M ﹤0.01% 2095
2024
Q2 		$18.2M Sell
1,684,924
-251,233
-13% -$2.72M ﹤0.01% 2002
2024
Q1 		$21.9M Buy
1,936,157
+220,737
+13% +$2.85M 0.01% 1935
2023
Q4 		$24.1M Buy
1,715,420
+21,420
+1% +$288K 0.01% 1892
2023
Q3 		$20.9M Buy
1,694,000
+91,444
+6% +$932K 0.01% 1895
2023
Q2 		$14.5M Buy
1,602,556
+1,389,244
+651% +$8.39M ﹤0.01% 2086
2023
Q1 		$740K Buy
213,312
+46,379
+28% +$189K ﹤0.01% 2964
2022
Q4 		$409 Buy
166,933
+78,144
+88% +$228K ﹤0.01% 3080
2022
Q3 		$245K Buy
+88,789
New +$377K ﹤0.01% 3200

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Dimensional Fund Advisors's OLMA Position: Q1 2026 in Review

Dimensional Fund Advisors increased its Olema Pharmaceuticals (OLMA) stake by 13% in Q1 2026, buying an estimated $2.76M and bringing the position to 1,082,434 shares worth $16.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2069.

Dimensional Fund Advisors first reported a position in OLMA in Q3 2022 and has held it in 15 quarters since. The position peaked at $24.1M in Q4 2023. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • Dimensional Fund Advisors held 1,082,434 shares of Olema Pharmaceuticals worth $16.1M as of Q1 2026.
  • Dimensional Fund Advisors bought 123,790 Olema Pharmaceuticals shares in Q1 2026, an estimated $2.76M.
  • Olema Pharmaceuticals made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #2069 holding.
  • Dimensional Fund Advisors first reported a position in Olema Pharmaceuticals in Q3 2022 and has held it in 15 quarters since.
  • Dimensional Fund Advisors's Olema Pharmaceuticals position peaked at $24.1M in Q4 2023.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.